Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Oliver M Dovey
Affiliation
ORCID
Career Start Year
2005
Papers
31
H Index
25
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
34638130
The CADM1 tumor suppressor gene is a major candidate gene in MDS with deletion of the long arm of chromosome 11.
Blood Adv
2022
35701672
Publisher Correction: UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Nat Genet
2022
34556857
Mutational synergy during leukemia induction remodels chromatin accessibility, histone modifications and three-dimensional DNA topology to alter gene expression.
Nat Genet
2021
33956058
SETBP1 overexpression acts in the place of class-defining mutations to drive FLT3-ITD-mutant AML.
Blood advances
2021
32728019
Author Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
Nat Commun
2020
31911614
Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
Nat Commun
2020
31827282
HBO1 is required for the maintenance of leukaemia stem cells.
Nature
2020
31235852
SOCS2 is part of a highly prognostic 4-gene signature in AML and promotes disease aggressiveness.
Scientific Reports
2019
31767858
The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia.
Nat Commun
2019
29364867
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.
Nature
2018
29282219
Mutant calreticulin knockin mice develop thrombocytosis and myelofibrosis without a stem cell self-renewal advantage.
Blood
2018
29736013
UTX-mediated enhancer and chromatin remodeling suppresses myeloid leukemogenesis through noncatalytic inverse regulation of ETS and GATA programs.
Nat Genet
2018
28835438
Molecular synergy underlies the co-occurrence patterns and phenotype of <i>NPM1</i>-mutant acute myeloid leukemia.
Blood
2017
28794285
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib.
Science Translational Medicine
2017
27757418
Promiscuous targeting of bromodomains by bromosporine identifies BET proteins as master regulators of primary transcription response in leukemia.
Sci Adv
2016
27175030
Identification of a germline F692L drug resistance variant in cis with Flt3-internal tandem duplication in knock-in mice.
Haematologica
2016
27760321
A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.
Cell Rep
2016
24958871
Histone deacetylase (HDAC) 1 and 2 are essential for accurate cell division and the pluripotency of embryonic stem cells.
Proceedings of the National Academy of Sciences of the United States of America
2014
23287868
Histone deacetylase 1 and 2 are essential for normal T-cell development and genomic stability in mice.
Blood
2013
23478666
A powerful molecular synergy between mutant Nucleophosmin and Flt3-ITD drives acute myeloid leukemia in mice.
Leukemia
2013
20647764
Emphasizing the positive: A role for histone deacetylases in transcriptional activation.
Cell Cycle
2010
20713442
Lysine-specific demethylase 1 regulates the embryonic transcriptome and CoREST stability.
Mol Cell Biol
2010
20404188
Histone deacetylase 1 (HDAC1), but not HDAC2, controls embryonic stem cell differentiation.
Proceedings of the National Academy of Sciences of the United States of America
2010
18391979
Loss of Rassf1a cooperates with Apc(Min) to accelerate intestinal tumourigenesis.
Oncogene
2008
17571346
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
Nature
2007
17567991
Butyrate mediates decrease of histone acetylation centered on transcription start sites and down-regulation of associated genes.
Genome Res
2007
17567990
The landscape of histone modifications across 1% of the human genome in five human cell lines.
Genome Res
2007
16823893
Array CGH profiling of favourable histology Wilms tumours reveals novel gains and losses associated with relapse.
J Pathol
2006
17122085
Accurate and reliable high-throughput detection of copy number variation in the human genome.
Genome Res
2006
16710414
The DNA sequence and biological annotation of human chromosome 1.
Nature
2006
16221759
Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays.
Hum Mol Genet
2005
1 - 31 of 31
Column Actions
Search
Recommended Authors
Collaborators
Cordelia Langford
Co-authored papers
7
Allan Bradley
The Wellcome Trust Sanger Institute
Co-authored papers
6
Peter Ellis
Co-authored papers
5
Nigel P Carter
4Wellcome Trust Sanger Institute
Co-authored papers
5
Robert Andrews
Co-authored papers
5
Ian Dunham
European Bioinformatics Institute (EMBL-EBI)
Co-authored papers
5
Pawandeep Dhami
Co-authored papers
4
Sarah Wilcox
Co-authored papers
4
Gayle K Clelland
Co-authored papers
4
Brian J P Huntly
University of Cambridge
Co-authored papers
4
Christof Koch
Co-authored papers
4
Guramrit Singh
Co-authored papers
3
Kosuke Yusa
Wellcome Sanger Institute
Co-authored papers
3
Adam Ameur
Co-authored papers
3
Gregory Lefebvre
Co-authored papers
3
David Vetrie
Co-authored papers
3
Claes Wadelius
Co-authored papers
3
Stefan Enroth
Co-authored papers
3
Yi Zheng
Children's Hospital Research Foundation
Co-authored papers
3
Krzysztof Mr??zek
The Ohio State Comprehensive Cancer Center
Co-authored papers
3
Nathalie Conte
The Wellcome Trust Sanger Institute
Co-authored papers
3
Alvaro Rada-Iglesias
Co-authored papers
3
Eric Wang
Co-authored papers
3
Keith D James
Wellcome Trust Sanger Institute
Co-authored papers
3
Jan Komorowski
Co-authored papers
3
Eshwar Meduri
University of Cambridge
Co-authored papers
3
Joanna C Fowler
Co-authored papers
2
David Swarbreck
Co-authored papers
2
Zhiping Weng
University of Massachusetts Medical School
Co-authored papers
2
Robert W Plumb
Co-authored papers
2
1 - 30